Upload

Loading...

Canaccord's Adam Cutler Likes Vivus, Orexigen Stocks

246 views

Loading...

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 23, 2012

Dec. 22 (Bloomberg) -- Adam Cutler, an analyst with Canaccord Genuity, talks about the outlook for weight loss drugs made by Arena Pharmaceuticals Inc., Vivus Inc. and Orexigen Therapeutics Inc. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up Next


Sign in to add this to Watch Later

Add to